Bibliografia

1. Salvia A, Rossini A, Balice MP, Terziani S, Guaglianone E, Donelli G. Infezioni da Staphylococcus aureus meticillino-resistente in strutture ospedaliere di riabilitazione neuromotoria: uno studio pilota della Fondazione Santa Lucia. Rapporti ISTISAN 2006; 06/46: 29.

2. Peacock SJ, de Silva I, Lowy FD. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 2001; 9 (12): 605-10.

3. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344 (1): 11-6.

4. Casewell MW, Hill RL. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986; 18 (Suppl A): 1-12.

5. Donelli G, Francolini I, Di Carlo V, Di Rosa R, Mastrilli F, Antonelli M, Fadda G. Protocollo per la prevenzione, diagnosi e terapia delle infezioni associate a cateteri venosi centrali. Rapporti ISTISAN 2002; 02/34: 33.

6. Donelli G, Di Carlo V, Guaglianone E, Francolini I, Di Rosa R, Antonelli M, Fadda G, Parisi AI, Musco S, Ierna A, Mastrilli F. Protocollo per la prevenzione, la diagnosi e la terapia delle infezioni delle vie urinarie associate ai cateteri vescicali. Rapporti ISTISAN 2003; 03/40: 43.

7. Donelli G, Guaglianone E, Antonelli M, Fadda G, Ierna A, Salvia A. Infezioni associate alle ulcere da pressione: metodologie di prevenzione, diagnosi e trattamento. Rapporti ISTISAN 2005; 05/41: 23.

8. Ellis SL, Finn P, Noone M, and Leaper DJ. Eradication of methicillin-resistant Staphylococcus aureus from pressure sores using warming therapy. Surg Infect (Larchmt) 2003; 4 (1): 53-5.

9. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10 (4): 781-91.

10. Jevons MP. “Celbenin”-resistant Staphylococci. Br Med J 1961; 1: 124-5.

11. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24 (Suppl 1): S74-S79.

12. Rosdahl VT, Knudsen AM. The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991; 12 (2): 83-8.

13. The Microbiology Surveillance Network of Northern France. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum [beta]-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. Journal of Hospital Infection 2002; 52 (2): 107-13.

14. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9 (5): 891-907.

15. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9 (8): 978-84.

16. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Etienne J, Richet H. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35 (7): 819-24.

17. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Hancock GA, Yee YC, Miller JM, Yu VL. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114 (2): 107-12.

18. Minary-Dohen P, Bailly P, Bertrand X, Talon D. Methicillin-resistant Staphylococcus aureus (MRSA) in rehabilitation and chronic-care-facilities: what is the best strategy? BMC Geriatr 2003; 3: 5.

19. Grundmann H, ires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368 (9538): 874-85.

20. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10 (9): 1627-34.

21. Boccia D, D’Ancona F, Salmaso S, Monaco M, Del GM, D’Ambrosio F, Giannitelli S, Lana S, Fokas S, Pantosti A. Antibiotic-resistance in Italy: activity of the first year of the surveillance project AR-ISS. Ann Ig 2005; 17 (2): 95-110.

22. Borg M, Scicluna E, De KM, Van dS-B, Tiemersma E, Gur D, Ben RS, Rasslan O, Elnassar Z, Benbachir M, Pieridou BD, Rahal K, Daoud Z, Grundmann H, Monen J. Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project. Euro Surveill 2006; 11 (7): 164-7.

23. Bradley SF. Methicillin-resistant Staphylococcus aureus in nursing homes. Epidemiology, prevention and management. Drugs Aging 1997; 10 (3): 185-98.

24. Salaripour M, McKernan P, Devlin R. A multidisciplinary approach to reducing outbreaks and nosocomial MRSA in a university-affiliated hospital. Healthc Q 2006; 9 (Spec No): 54-60.

25. Nijssen S, Bonten MJ, Weinstein RA. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis 2005; 40 (3): 405-9.

26. Brun-Buisson C & Girou E. Isolation of patients with MRSA infection. Lancet 2005; 365 (9467): 1303-5.

27. Kobayashi H. National hospital infection surveillance on methicillin-resistant Staphylococcus aureus. Dermatology 2006; 212 (Suppl 1): 1-3.

28. Mishal J, Sherer Y, Levin Y, Katz D, and Embon E. Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting. Scand J Infect Dis 2001; 33 (7): 498-501.

29. Wagenvoort JH. Dutch measures to control MRSA and the expanding European Union. Euro Surveill 2000; 5 (3): 26-8.